PRECISEDX
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features, enabling better and more personalized treatment and outcomes. Clinical teams can rely on PreciseDx for unmatched insights and actionable intelligence in determining the best treatment for each patient. Combining the power of artificial intelligence with its proprietary Morphology Feature Arrayâ„¢, PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making.
PRECISEDX
Social Links:
Industry:
Health Care
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.precisedx.ai
Total Employee:
1+
Status:
Active
Contact:
646-818-9330
Email Addresses:
[email protected]
Total Funding:
31.45 M USD
Technology used in webpage:
Euro Apple Mobile Web Clips Icon Amazon LetsEncrypt AJAX Libraries API CloudFront Amazon S3 CDN Gravity Forms GoDaddy Fastly
Similar Organizations
Foundation Medicine
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Current Employees Featured
Founder
Investors List
LabCorp
LabCorp investment in Series B - PreciseDx
GenHenn Venture
GenHenn Venture investment in Series B - PreciseDx
Eventide
Eventide investment in Series B - PreciseDx
Quest Diagnostics
Quest Diagnostics investment in Series B - PreciseDx
IBM Ventures
IBM Ventures investment in Series A - PreciseDx
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Series A - PreciseDx
Mount Sinai Health System
Mount Sinai Health System investment in Series A - PreciseDx
Agilent Technologies
Agilent Technologies investment in Series A - PreciseDx
Key Employee Changes
| Date | New article |
|---|---|
| 2023-02-21 | PreciseDx Appoints Bradley Gendell as Chief Financial Officer |
Official Site Inspections
http://www.precisedx.ai Semrush global rank: 9.69 M Semrush visits lastest month: 369
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "PreciseDx"
PreciseDx
Redefining the standard of cancer care. PreciseBreast TM uses visual AI-analysis of tissue samples already collected to objectively classify breast cancer patients into two cohorts of low …See details»
Our Team - PreciseDx
Executive Leadership. PreciseDx is led by the foremost experts in the use of artificial intelligence in systems pathology. The Company’s leaders have deep expertise in diagnostics, pathology, …See details»
PreciseDx - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 646-818-9330 PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features, enabling better and …See details»
PreciseDx Company Profile 2024: Valuation, Funding
Developer of artificial intelligence-guided pathology diagnostics designed to improve patient outcomes in the field of cancer and other diseases. The company's commercial, regulatory and translational research experience …See details»
Labcorp, Quest Diagnostics back PreciseDx's $20.7M series B
Aug 21, 2024 Cancer diagnostics startup PreciseDx picked up $20.7 million in series B funding as it ramps up commercialization efforts for its AI-based breast cancer risk assessment.See details»
PreciseDx's digital pathology AI on par with genomic testing in ...
2 days ago A study from PreciseDx showed that its artificial-intelligence-guided pathology test could help predict a patient’s chances of their breast cancer returning on par with a leading …See details»
PreciseDx - Overview, News & Similar companies | ZoomInfo.com
View PreciseDx (www.precisedx.ai) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more. …See details»
PreciseDx Secures $20.7M to Improve Diagnostics in Oncology …
Sep 3, 2024 PreciseDx, a pioneering medical technology leveraging the power of artificial intelligence (AI) to improve diagnostics in oncology, has secured $20.7 million in a series B …See details»
PreciseDx Company Profile - Office Locations, Competitors ... - Craft
PreciseDx is a cancer risk stratification company that provides patient-specific risk information through the analysis of morphology features. Its AI-powered predictive platform creates …See details»
PreciseDx Secures $20.7 Million Series B to Advance AI-Powered …
NEW YORK, Aug. 21, 2024 /PRNewswire/ -- PreciseDx®, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for new, morphology-driven disease analysis, …See details»
AI Digital Pathology | Who We Serve | PreciseDx
PreciseDx serves patients, providers, and payers as the 1st commercial digital pathology lab with proprietary AI algorithms and diagnostic modules of clinical utility. Contact; ... The PreciseDx …See details»
PreciseDx Secures $20.7 Million Series B to Advance AI-Powered …
Aug 21, 2024 PreciseDx®, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for new, morphology-driven disease analysis, today announced that it has …See details»
PreciseDx secures funding to advance AI-powered breast cancer …
Aug 27, 2024 PreciseDx, a leading innovator in oncology diagnostics leveraging artificial intelligence (AI) for new, morphology-driven disease analysis, has announced that it has …See details»
PreciseDx AI diagnostic can detect early-stage Parkinson's
Dec 2, 2024 PreciseDx's diagnostic relies instead on peripheral nerve tissue taken from the salivary glands of the living patient, using AI to look for LTS and other morphological features …See details»
PreciseDx Early Parkinson's Disease | Tissuepathology.com
Apr 21, 2022 PreciseDx’s AI Morphology Feature Array was able to detect Parkinson’s pathology in image patches from biopsy samples with 99% sensitivity and 99% specificity as …See details»
PreciseDx: NY State Breast Cancer | Tissuepathology.com
Oct 25, 2023 Image source PreciseDx AI powered approach. Once breast cancer is detected, pathologists and oncologists must design an effective treatment plan which is currently limited …See details»
Why PreciseDx
PreciseDx was formed with the vision to improve the multi-disciplinary team’s workflow by speeding the process of reporting tumor risk for newly diagnosed breast cancer patients. ...See details»
PreciseDx AI Platform Predicts Early-Stage Breast Cancer Recurrence
Jan 23, 2023 PreciseDx, a provider in AI-powered, patient-specific disease analysis, announced a recent publication in Breast Cancer Research that demonstrated the ability of the company’s …See details»
PreciseBreast is reliability you can see
5 days ago PreciseBreast deploys visual AI to analyze the cellular morphology of tissue samples already collected – the same slides pathologists use for tumor grading. ... PreciseDx raises …See details»